Basisstatistiken
| CIK | 1115143 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Acusphere, Inc.
SEC Filings (Chronological Order)
Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.
| January 10, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION January 10, 2017 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 Acusphere, Inc. |
|
| February 21, 2008 |
Michael H. Bison 617.570.1933 mbison@ goodwinprocter.com Goodwin Procter LLP Counsellors at Law Exchange Place Boston, MA 02109 T: 617.570.1000 F: 617.523.1231 VIA EDGAR February 21, 2008 Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549-3561 Mail Stop — 0610 Attention: Mr. John L. Krug Re: Acusphere, Inc. Preliminary proxy statement Filed |
|
| February 14, 2008 |
Mail Stop 0610 February 14, 2008 Ms. Sherri C. Oberg President and Chief Executive Officer Acusphere, Inc. 500 Arsenal Street Watertown, Massachusetts 02472 Re: Acusphere, Inc. Preliminary proxy statement filed February 12, 2008 File No. 0-50405 Dear Ms. Oberg: We have reviewed your filing solely with respect to the proposed reverse stock split and have the following comments. Where indicated, we |
